Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term clinical trials. Found 15 abstracts

Ristau BT, Manola J, Haas NB, Heng DY, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG. Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial. J Urol. 2018 Jan;199(1):53-9.   PMCID: PMC5800986
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Nov 17;28(4):528-36.
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Jan;28(4):528-36.
Uzzo RG, Horwitz EM, Plimack ER. Fox Chase Cancer Center's Genitourinary Division: a national resource for research, innovation and patient care. Future Oncol. 2016 Feb 17;12(7):887-91.
Bilusic M, Wong YN. Anti-angiogenesis in prostate cancer: knocked down but not out. Asian journal of andrology. 2014 May;16(3):372-7.   PMCID: PMC4023362
Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS Care. 2006 Jan;20(2):253-60.
Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, Scott C, Curran W. Outcomes research in cancer clinical trial cooperative groups: The RTOG model. Quality of Life Research. 2004 Aug;13(6):1025-41.
Gaskin DJ, Weinfurt KR, Castel LD, DePuy V, Li Y, Balshem A, Benson A, Burnett CB, Corbett S, Marshall J, Slater E, Sulmasy DR, Van Echo D, Meropol NJ, Schulman KA. An exploration of relative health stock in advanced cancer patients. Medical Decision Making. 2004 Nov;24(6):614-24.
Konski A, Watkins-Bruner D. The RTOG Outcomes Model: economic end points and measures. Expert Opinion on Pharmacotherapy. 2004 Mar;5(3):513-9.
Clapper ML. Chemopreventive activity of oltipraz. Pharmacology & Therapeutics. 1998 Apr;78(1):17-27.
Clapper ML, Szarka CE. Glutathione S-transferases - biomarkers of cancer risk and chemopreventive response. Chemico-Biological Interactions. 1998 Apr 24;112:377-88.
Simpson JR, Scott CB, Rotman M, Curran WJ, Constine LS, Fischbach AJ, Asbell SO. Race and prognosis of brain tumor patients entering multicenter clinical trials - A report from the Radiation Therapy Oncology Group. American Journal of Clinical Oncology-Cancer Clinical Trials. 1996 Apr;19(2):114-20.
Scott CB, Nelson JS, Farnan NC, Curran WJ, Murray KJ, Fischbach J, Gaspar LE, Nelson DF. Central Pathology Review in Clinical-Trials for Patients with Malignant Glioma - a Report of Radiation-Therapy Oncology Group-83-02. Cancer. 1995 Jul 15;76(2):307-13.
Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR. Localized Carcinoma of the Prostate (Stage-T1b, Stage-T1c, Stage-T2, and Stage-T3) - Review of Management with External- Beam Radiation-Therapy. Cancer. 1993 Dec;72(11):3156-73.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term clinical trials

clinical trials United States Clinical Trials as Topic cancer perceptions epidemiology Trust irradiation ethnology male f344 rats Urban Population Male HIV Seropositivity CLINICAL-TRIALS Female Middle Aged Patient Acceptance of Health Care HIV Infections prostate cancer minorities KeyWords Plus: Adolescent aids CELL LUNG-CANCER Minority Groups lymphadenectomy lung-cancer ADJUSTED SURVIVAL ANALYSIS Motivation Hiv Sex Factors Aged Communication Barriers Attitudes Health Knowledge-Practice perceptual mapping population Social Stigma oltipraz psychology Young Adult Perception chemoprevention economic analysis immunotherapy Surveys and Questionnaires colorectal-cancer Focus Groups Adult Head and Neck Neoplasms ADVANCED SOLID TUMORS hairy leukoplakia adjuvant therapy Monoclonal Antibodies risk radical prostatectomy PHASE-II TRIAL adverse effects precision medicine life prognosis bis-chlorethyl nitrosourea aflatoxin GST s-transferase-mu human papillomavirus experimental murine colitis smoking cessation prostate-specific low-income distant metastasis genetic- PROSTATE-CANCER immunology DOSE-ESCALATION smoking-cessation ENDOTHELIAL GROWTH-FACTOR colon cancer MALIGNANT GLIOMA race tumor-control National Cancer Institute (US) treatment related morbidity astrocytoma Immunologic Factors dietary oltipraz susceptibility RADIOTHERAPY diagnosis anaplastic astrocytoma temporary ir-192 implantation physicians malignant glioma checkpoint inhibitors behavioral interventions AIDS human hepatocytes b-1 PROTOCOL risk-factors immunodeficiency-virus-infection Immunotherapy Molecular Targeted Therapy colon- DOUBLE-BLIND PLUS PREDNISONE attitudes head and neck cancer phase-i RANDOMIZED-TRIAL polymorphism human-leukocytes antigen levels human-papillomavirus infection genitourinary cancer broccoli Andrology health services accessibility hiv COST-EFFECTIVENESS ANALYSIS mu detoxification enzyme inducer glioblastoma multiforme cellular phone bladder cancer cigarette-smoking PROGRESSION-FREE SURVIVAL Patient Selection TYROSINE KINASE HIV SOUTHWEST-ONCOLOGY-GROUP HEALTH ECONOMICS ANALYSIS decision making animal models targeted therapy 5-(2-pyrazinyl)-4-methyl-1 HORMONAL-THERAPY colon carcinogenesis ADVANCED PROSTATE-CANCER carcinoma of the prostate antigen quality overall survival Neoplasm Staging i clinical-trials therapeutic use expectations outcomes research 2-dithiol-3-thione oltipraz glioma COSTS
Last updated on Friday, January 03, 2020